{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:45:23Z","timestamp":1758041123883,"version":"3.44.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.ajog.2013.01.039","type":"journal-article","created":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T14:18:02Z","timestamp":1359037082000},"page":"397.e1-397.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Down syndrome maternal serum marker screening after 18 weeks of gestation: a countrywide study"],"prefix":"10.1016","volume":"208","author":[{"given":"Sophie","family":"Dreux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Czerkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elie","family":"Azria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc-Antoine","family":"Four\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2013.01.039_bib1","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/bmj.297.6653.883","article-title":"Maternal serum screening for Down's syndrome in early pregnancy","volume":"297","author":"Wald","year":"1988","journal-title":"Br Med J"},{"key":"10.1016\/j.ajog.2013.01.039_bib2","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJM199208273270902","article-title":"Prenatal screening for Down's syndrome with use of maternal serum markers","volume":"327","author":"Haddow","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2013.01.039_bib3","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0378-3782(96)01814-2","article-title":"Established markers in second trimester maternal serum","volume":"47","author":"Cuckle","year":"1996","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ajog.2013.01.039_bib4","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0002-9378(97)70400-9","article-title":"Maternal serum screening for Down syndrome in the United States: a 1995 survey","volume":"176","author":"Palomaki","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.039_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0301-2115(00)00431-0","article-title":"Biochemical screening for Down syndrome","volume":"92","author":"Cuckle","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2013.01.039_bib6","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1471-0528.2000.tb11619.x","article-title":"One stop clinic for assessment of risk for fetal anomalies: report of the first year of prospective screening for chromosomal anomalies in the first trimester","volume":"107","author":"Spencer","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2013.01.039_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/pd.1970130106","article-title":"Second trimester trisomy 21 maternal serum marker screening","volume":"13","author":"Muller","year":"2002","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2013.01.039_bib8","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/pd.1970130804","article-title":"First-trimester biochemical screening for fetal chromosome abnormalities and neural tube defects","volume":"13","author":"Aitken","year":"1993","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2013.01.039_bib9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/pd.1970130714","article-title":"Serum PAPP-A levels are depressed in women with fetal Down syndrome in early pregnancy","volume":"13","author":"Muller","year":"1993","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2013.01.039_bib10","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1471-0528.1999.tb08183.x","article-title":"Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review","volume":"106","author":"Spencer","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2013.01.039_bib11","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2105\/AJPH.94.3.484","article-title":"Socioeconomic barriers to informed decisionmaking regarding maternal serum screening for Down syndrome: results of the French National Perinatal Survey of 1998","volume":"94","author":"Khoshnood","year":"2004","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ajog.2013.01.039_bib12","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jgyn.2012.04.014","article-title":"Trends in perinatal health in France from1995 to 2010","volume":"41","author":"Blondel","year":"2012","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.ajog.2013.01.039_bib13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejogrb.2011.09.028","article-title":"Improvement of first-trimester ultrasound screening in socially deprived settings through a community-based perinatal network","volume":"159","author":"Azria","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2013.01.039_bib14","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/pd.451","article-title":"Down syndrome maternal serum marker screening after 18 weeks' gestation","volume":"22","author":"Muller","year":"2002","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2013.01.039_bib15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/uog.2793","article-title":"Prediction of delivery date by sonography in the first and second trimester","volume":"28","author":"Olesen","year":"2006","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.039_bib16","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/clinchem\/45.8.1278","article-title":"Software for prenatal trisomy 21 risk calculation: comparative study of seven software packages","volume":"8","author":"Muller","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajog.2013.01.039_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0749-3797(01)00315-4","article-title":"Barriers to prenatal care in Europe","volume":"21","author":"Delvaux","year":"2001","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ajog.2013.01.039_bib18","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/pd.197","article-title":"Minor sonographic signs of trisomy 21 at 15-20 weeks' gestation in foetuses born without malformations: a prospective study","volume":"21","author":"Viora","year":"2001","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2013.01.039_bib19","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/pd.2531","article-title":"The history of the second-trimester sonographic markers for detecting fetal Down syndrome, and their current role in obstetric practice","volume":"30","author":"Benacerraf","year":"2010","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2013.01.039_bib20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/000456320203900604","article-title":"Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimesters of pregnancy","volume":"39","author":"Spencer","year":"2002","journal-title":"Ann Clin Biochem"},{"issue":"Suppl A","key":"10.1016\/j.ajog.2013.01.039_bib21","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.placenta.2004.01.007","article-title":"Impact of trisomy 21 on human trophoblast behaviour and hormonal function","author":"Pidoux","year":"2004","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2013.01.039_bib22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1210\/jc.2003-030668","article-title":"Trophoblast production of a weakly bioactive human chorionic gonadotropin in trisomy 21-affected pregnancy","volume":"89","author":"Frendo","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl","key":"10.1016\/j.ajog.2013.01.039_bib23","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.placenta.2011.11.007","article-title":"Review: human trophoblast fusion and differentiation: lessons from trisomy 21 placenta","volume":"33","author":"Pidoux","year":"2012","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2013.01.039_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1258\/000456303321610501","article-title":"The effect of temporal variation in biochemical markers of trisomy 21 across the first and the second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome","volume":"40","author":"Spencer","year":"2003","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.ajog.2013.01.039_bib25","doi-asserted-by":"crossref","first-page":"205.e1","DOI":"10.1016\/j.ajog.2010.12.060","article-title":"Nonivasive detection of fetal trisomy 21 by sequencing of DANN in maternal blood: a study in a clinical setting","volume":"204","author":"Ehrich","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.039_bib26","doi-asserted-by":"crossref","first-page":"137.e1","DOI":"10.1016\/j.ajog.2012.05.021","article-title":"Non-invasive chromosomal evaluation (NICE) study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18","volume":"207","author":"Norton","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.039_bib27","doi-asserted-by":"crossref","first-page":"374.e1","DOI":"10.1016\/j.ajog.2012.08.033","article-title":"Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population","volume":"207","author":"Nicolaides","year":"2012","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937813000860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937813000860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:52:11Z","timestamp":1757587931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937813000860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0002937813000860"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2013.01.039","relation":{},"ISSN":["0002-9378"],"issn-type":[{"type":"print","value":"0002-9378"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Down syndrome maternal serum marker screening after 18 weeks of gestation: a countrywide study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2013.01.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}